Member Info for dan1nat1

Well news is due Q2 ;)

Moving quick today, could be a nice morning!

I take it you mean £1 short term...I want far more than that within the next 18 months ;)

5.75p v 6p

I said at time it flashed up on the bid side during auction.

You have to wonder why this has not happened yet -

“Appointment of a Chief Financial Officer

Following the appointment of Tim Sykes as Chief Executive Officer on 10 January 2019, a process for the recruitment of a new Chief Financial Officer commenced. The Board has identified a preferred candidate who has agreed to join the Group, subject to contract, and the Board looks forward to being able to announce the appointment in the near future.”

Unless there definition of near future is different to mine? I’m expecting a big announcement soon.

That does mean that 1m trade yesterday was most probably a buy...

Nice delayed buy!

I literally posted the part of the RNS this morning that talks about the Japanese results and when we can expect them.

This bit looks interesting, we have discussed here before that this could be an option, sub set first then the rest of the patients to follow -

"Traumakine marks a significant step for Faron as we remain confident in the impact this future medicine can bring, first to a subset of ARDS patients and then hopefully to all of them."

Did you not read the RNS this week?

“The Company continues to await the outcome of the trial and clinical study report from the phase III Traumakine ARDS trial that has been conducted by Japanese partner, Maruishi. This data is expected to be received by the Company in March or April 2019, however the timing and presentation of the data is outside of the control of the Company.”

That 1m could have been a buy, it was on the bid side on L2 at the last auction. Wasn’t showing other than when in auction.

Today’s RNS does say subject to the outcome of YODA, maybe it’s nearly complete and they are confident enough about what it will confirm?

“Subject to completion of the Subscription and the outcome of the YODA trial, and to enable Faron to make a marketing approval application, the Company is planning for a new phase III trial of Traumakine in the treatment of ARDS.”

I think the next update will be an interview, and I’m hoping to see it tomorrow.

Looks like LSE dont want to link to the interview.

Loads of news due in the next month or so, and today is another day without any big delayed CF sales, could it be we can break 1p with our current newsflow...

Dracula,

I know what you mean, but it would be rare to see a placing about the current market price.

The 70p you refer to was actually 70 cent, it was the price in Euros.

Most placings sink to that level as everyone knows they will be sold into, with this one being so limited I'm not sure we will see the sell off you normally would.

The fact is it now looks like Traumakine is not the write off some thought it was, and this could actually be a big turning point for FARN.

This is AIM, show the mm's the money and tell them what you want to happen... ;)

Two buys of 103123 shares, seems an odd number for someone to pick?

Not a bad day today, but still no TR1 from our buyer...

"when read in conjunction with the recent interview this has to be because they failed to secure a partner before needing the cash."

Kev,

I am just hoping the relatively small raise is because they are at advanced talks with at least one partner.

Was 60p, so not as bad a discount as it could have been.

Dracula,

Its not about fairness, its about the current market why would anyone currently want to pay 70p when they can buy in the market around 65p?